BioSerenity Overview

  • Founded
  • 2013
Founded
  • Status
  • Private
  • Employees
  • 650
Employees
  • Latest Deal Type
  • Corporate
  • Investors
  • 10

BioSerenity General Information

Description

Developer of digitally connected devices designed to optimize the patient pathways in several chronic diseases. The company's devices are based on data retrieval and interpretation of electrophysiological signals such as electroencephalogram, electrocardiogram and polysomnography, enabling patients and physicians to remotely follow continuous electrophysiological signals in the fields of cardiology, neurology and sleep disorders.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Monitoring Equipment
Other Industries
Diagnostic Equipment
Decision/Risk Analysis
Primary Office
  • Institut du Cerveau et de la Moelle Epinière - 47
  • Boulevard de l'hôpital
  • 75013 Paris
  • France
+33 01 00 00 00 00

BioSerenity Timeline

2018201920202021
Financing RoundFinancing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

BioSerenity Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Corporate 05-Nov-2019 000.00 Completed Generating Revenue
5. Later Stage VC (Series B) 18-Jun-2019 000.00 000.00 00000 Completed Generating Revenue
4. Early Stage VC (Series A) 20-Sep-2017 000.00 000.00 000.00 Completed Startup
3. Corporate 29-Jun-2016 00.000 Completed Startup
2. Seed Round 04-Jun-2015 $3.35M $3.35M 000.00 Completed Startup
1. Accelerator/Incubator Completed Startup
To view BioSerenity’s complete valuation and funding history, request access »

BioSerenity Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
C Shares 000,000 00.000000 0000.00 0000.00 00 0000.00 00.000
B Shares 0,000 00.000000 0000.00 0000.00 00 0000.00 0.000
B Shares 00,000 00.000000 0000.00 0000.00 00 0000.00 0.000
B Shares 00,000 00.000000 0000.00 0000.00 00 0000.00 00.000
B Shares 13,446 $1.122006 $166.89 $166.89 1x $166.89 2.73%
A Shares 66,936 $1.122006 $50.29 $50.29 1x $50.29 13.61%
To view BioSerenity’s complete cap table history, request access »

BioSerenity Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Developer of digitally connected devices designed to optimize the patient pathways in several chronic diseases. The comp
Monitoring Equipment
Paris, France
650 As of 2021
000.00
000000000000 000.00

00000 00

rem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et
0000000000 000000000
Pikesville, MD
00 As of 0000
00.000
000000 0

00000000

fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia des
0000000000 000000000
San Jose, CA
00 As of 0000
00000
000000000 00000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

BioSerenity Competitors (9)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Aidar Health Venture Capital-Backed Pikesville, MD 00 00.000 000000 0
000000000000 Venture Capital-Backed San Jose, CA 00 00000 000000000 00000
00000000 Venture Capital-Backed Mountain View, CA 00 00000 00000000000 00000
00000 Venture Capital-Backed Madrid, Spain 00 00.00 000000000 00.00
0000000000 Formerly VC-backed Belfast, United Kingdom 00 00.000 000000&0 00.000
You’re viewing 5 of 9 competitors. Get the full list »

BioSerenity Executive Team (7)

Name Title Board Seat Contact Info
Pierre-Yves Frouin Co-Founder, Principal, President, Chief Executive Officer & Chairman
Marc Frouin Chief Operating Officer, General Manager & Board Member
Stephen Shirk Director of Finance
Jeff Powell Executive
Zafeiria Diamanti Executive
You’re viewing 5 of 7 executive team members. Get the full list »

BioSerenity Board Members (3)

Name Representing Role Since
Chantal Parpex MD Innovation Capital (Paris) Board Member 000 0000
Marc Frouin BioSerenity Chief Operating Officer, General Manager & Board Member 000 0000
Pierre-Yves Frouin BioSerenity Co-Founder, Principal, President, Chief Executive Officer & Chairman 000 0000
To view BioSerenity’s complete board members history, request access »

BioSerenity Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

BioSerenity Investors (10)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
SCOR Global Life Americas Corporation Minority 000 0000 000000 0
Dassault Systemes Corporation Minority 000 0000 000000 0
SCOR Life & Health Ventures Corporate Venture Capital Minority 000 0000 000000 0
Bpifrance Sovereign Wealth Fund Minority 000 0000 000000 0
Innovation Capital (Paris) Venture Capital Minority 000 0000 000000 0
You’re viewing 5 of 10 investors. Get the full list »

BioSerenity Acquisitions (1)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
00000000 08-Jun-2019 000000000000000000 Laboratory Services (Healthcare)
To view BioSerenity’s complete acquisitions history, request access »

BioSerenity Subsidiaries (1)

Company Name Industry Location Founded
00000000 Laboratory Services (Healthcare) Columbia, SC
To view BioSerenity’s complete subsidiaries history, request access »